-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, U4ASr38M/K9Wr3PuAigb9N48H3Nu8kn7CRfyKEg9yD6nbyV4ocp05m1DdZWaIZf3 nI4nnt+2Ut7npwD7f30l3A== 0000874015-08-000018.txt : 20080403 0000874015-08-000018.hdr.sgml : 20080403 20080403182635 ACCESSION NUMBER: 0000874015-08-000018 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080401 FILED AS OF DATE: 20080403 DATE AS OF CHANGE: 20080403 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ISIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000874015 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330336973 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1896 RUTHERFORD ROAD CITY: CARLSBAD STATE: CA ZIP: 92008 BUSINESS PHONE: 7609319200 MAIL ADDRESS: STREET 1: 1896 RUTHERFORD ROAD CITY: CARLSBAD STATE: CA ZIP: 92008 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BENNETT C FRANK CENTRAL INDEX KEY: 0001073387 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19125 FILM NUMBER: 08738782 BUSINESS ADDRESS: BUSINESS PHONE: 760-931-9200 MAIL ADDRESS: STREET 1: 1896 RUTHERFORD ROAD CITY: CARLSBAD STATE: CA ZIP: 92008 4 1 edgar.xml PRIMARY DOCUMENT X0202 4 2008-04-01 0000874015 ISIS PHARMACEUTICALS INC ISIS 0001073387 BENNETT C FRANK C/O ISIS PHARMACEUTICALS, INC. 1896 RUTHERFORD ROAD CARLSBAD CA 92008 0 1 0 0 Senior Vice President Common Stock 2008-04-01 2008-04-01 4 M 0 10000 5.25 A 10392 D Common Stock 2008-04-01 2008-04-01 4 S 0 10000 15.33 D 392 D Employee Stock Purchase (right to buy) 5.25 2008-04-01 2008-04-01 4 M 0 10000 0 D 2007-01-03 2013-01-02 Common Stock 10000 20322 D The purchase reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/12/08. The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/12/08. Grant of 1-3-06 to reporting person of stock options under the Isis Pharmaceuticals, Inc. 1989 Stock Option Plan. 25% of the shares subject to the option vested and became exercisable on 1-3-07. Thereafter, the remaining shares subject to the option vest and become exercisable in 36 equal monthly installments, at the rate of 7,581 shares per year. The option was exercisable as to 16,425 shares on 4-1-08. /s/C. Frank Bennett 2008-04-03 -----END PRIVACY-ENHANCED MESSAGE-----